1	An	_	DT	_	_	3	NMOD	_	_
2	experimental	_	JJ	_	_	3	NMOD	_	_
3	vaccine	_	NN	_	_	4	SBJ	_	_
4	can	_	MD	_	_	21	OBJ	_	_
5	alter	_	VB	_	_	4	VC	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	immune	_	JJ	_	_	8	NMOD	_	_
8	response	_	NN	_	_	5	OBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	people	_	NNS	_	_	9	PMOD	_	_
11	infected	_	VBN	_	_	10	APPO	_	_
12	with	_	IN	_	_	11	ADV	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	AIDS	_	NNP	_	_	15	NMOD	_	_
15	virus	_	NN	_	_	12	PMOD	_	_
16	,	_	,	_	_	21	P	_	_
17	a	_	DT	_	_	20	NMOD	_	_
18	prominent	_	JJ	_	_	20	NMOD	_	_
19	U.S.	_	NNP	_	_	20	NMOD	_	_
20	scientist	_	NN	_	_	21	SBJ	_	_
21	said	_	VBD	_	_	0	ROOT	_	_
22	.	_	.	_	_	21	P	_	_

1	However	_	RB	_	_	4	ADV	_	_
2	,	_	,	_	_	4	P	_	_
3	that	_	DT	_	_	4	SBJ	_	_
4	does	_	VBZ	_	_	0	ROOT	_	_
5	n't	_	RB	_	_	4	ADV	_	_
6	mean	_	VB	_	_	4	VC	_	_
7	they	_	PRP	_	_	8	SBJ	_	_
8	can	_	MD	_	_	6	OBJ	_	_
9	benefit	_	VB	_	_	8	VC	_	_
10	from	_	IN	_	_	9	ADV	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	vaccine	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	4	P	_	_

1	Its	_	PRP$	_	_	2	NMOD	_	_
2	effectiveness	_	NN	_	_	3	SBJ	_	_
3	ca	_	MD	_	_	0	ROOT	_	_
4	n't	_	RB	_	_	3	ADV	_	_
5	be	_	VB	_	_	3	VC	_	_
6	determined	_	VBN	_	_	5	VC	_	_
7	until	_	IN	_	_	6	TMP	_	_
8	a	_	DT	_	_	11	NMOD	_	_
9	large	_	JJ	_	_	11	NMOD	_	_
10	clinical	_	JJ	_	_	11	NMOD	_	_
11	trial	_	NN	_	_	12	SBJ	_	_
12	is	_	VBZ	_	_	7	SUB	_	_
13	undertaken	_	VBN	_	_	12	VC	_	_
14	by	_	IN	_	_	13	LGS	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	Army	_	NNP	_	_	14	PMOD	_	_
17	in	_	IN	_	_	13	TMP	_	_
18	January	_	NNP	_	_	17	PMOD	_	_
19	,	_	,	_	_	6	P	_	_
20	according	_	VBG	_	_	6	ADV	_	_
21	to	_	TO	_	_	20	PMOD	_	_
22	Robert	_	NNP	_	_	23	NAME	_	_
23	Redfield	_	NNP	_	_	21	PMOD	_	_
24	,	_	,	_	_	23	P	_	_
25	chief	_	NN	_	_	23	APPO	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	acquired	_	VBN	_	_	31	NMOD	_	_
28	immune	_	JJ	_	_	31	NMOD	_	_
29	deficiency	_	NN	_	_	31	NMOD	_	_
30	syndrome	_	NN	_	_	31	NMOD	_	_
31	research	_	NN	_	_	26	PMOD	_	_
32	at	_	IN	_	_	25	LOC	_	_
33	Walter	_	NNP	_	_	36	NAME	_	_
34	Reed	_	NNP	_	_	36	NAME	_	_
35	Army	_	NNP	_	_	36	NAME	_	_
36	Institute	_	NNP	_	_	32	PMOD	_	_
37	of	_	IN	_	_	36	NMOD	_	_
38	Research	_	NNP	_	_	37	PMOD	_	_
39	.	_	.	_	_	3	P	_	_

1	Dr.	_	NNP	_	_	2	TITLE	_	_
2	Redfield	_	NNP	_	_	4	NMOD	_	_
3	's	_	POS	_	_	2	SUFFIX	_	_
4	report	_	NN	_	_	22	SBJ	_	_
5	on	_	IN	_	_	4	NMOD	_	_
6	early	_	JJ	_	_	7	NMOD	_	_
7	experiments	_	NNS	_	_	5	PMOD	_	_
8	using	_	VBG	_	_	7	APPO	_	_
9	an	_	DT	_	_	11	NMOD	_	_
10	AIDS	_	NNP	_	_	11	NMOD	_	_
11	vaccine	_	NN	_	_	8	OBJ	_	_
12	made	_	VBD	_	_	11	APPO	_	_
13	by	_	IN	_	_	12	LGS	_	_
14	MicroGeneSys	_	NNP	_	_	13	PMOD	_	_
15	Inc.	_	NNP	_	_	14	POSTHON	_	_
16	of	_	IN	_	_	14	LOC	_	_
17	West	_	NNP	_	_	18	NAME	_	_
18	Haven	_	NNP	_	_	16	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	Conn.	_	NNP	_	_	18	APPO	_	_
21	,	_	,	_	_	22	P	_	_
22	came	_	VBD	_	_	0	ROOT	_	_
23	at	_	IN	_	_	22	LOC	_	_
24	a	_	DT	_	_	25	NMOD	_	_
25	meeting	_	NN	_	_	23	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	AIDS	_	NNP	_	_	29	NMOD	_	_
28	vaccine	_	NN	_	_	29	NMOD	_	_
29	researchers	_	NNS	_	_	26	PMOD	_	_
30	in	_	IN	_	_	22	LOC	_	_
31	Florida	_	NNP	_	_	30	PMOD	_	_
32	late	_	JJ	_	_	33	NMOD	_	_
33	Monday	_	NNP	_	_	22	TMP	_	_
34	.	_	.	_	_	22	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	vaccine	_	NN	_	_	7	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	VaxSyn	_	NNP	_	_	5	NAME	_	_
5	HIV-1	_	NNP	_	_	2	APPO	_	_
6	,	_	,	_	_	2	P	_	_
7	has	_	VBZ	_	_	0	ROOT	_	_
8	been	_	VBN	_	_	7	VC	_	_
9	safely	_	RB	_	_	10	MNR	_	_
10	given	_	VBN	_	_	8	VC	_	_
11	to	_	TO	_	_	10	DTV	_	_
12	14	_	CD	_	_	13	NMOD	_	_
13	people	_	NNS	_	_	11	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	some	_	DT	_	_	16	NMOD	_	_
16	of	_	IN	_	_	18	SBJ	_	_
17	whom	_	WP	_	_	16	PMOD	_	_
18	are	_	VBP	_	_	13	NMOD	_	_
19	experiencing	_	VBG	_	_	18	VC	_	_
20	substantial	_	JJ	_	_	21	NMOD	_	_
21	increases	_	NNS	_	_	19	OBJ	_	_
22	in	_	IN	_	_	21	LOC	_	_
23	certain	_	JJ	_	_	24	NMOD	_	_
24	antibodies	_	NNS	_	_	22	PMOD	_	_
25	.	_	.	_	_	7	P	_	_

1	``	_	``	_	_	31	P	_	_
2	The	_	DT	_	_	4	NMOD	_	_
3	conventional	_	JJ	_	_	4	NMOD	_	_
4	wisdom	_	NN	_	_	5	SBJ	_	_
5	used	_	VBN	_	_	31	OBJ	_	_
6	to	_	TO	_	_	5	OPRD	_	_
7	be	_	VB	_	_	6	IM	_	_
8	that	_	IN	_	_	7	PRD	_	_
9	you	_	PRP	_	_	10	SBJ	_	_
10	could	_	MD	_	_	8	SUB	_	_
11	n't	_	RB	_	_	10	ADV	_	_
12	modify	_	VB	_	_	10	VC	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	immune	_	JJ	_	_	15	NMOD	_	_
15	response	_	NN	_	_	12	OBJ	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	an	_	DT	_	_	19	NMOD	_	_
18	infected	_	JJ	_	_	19	NMOD	_	_
19	individual	_	NN	_	_	16	PMOD	_	_
20	''	_	''	_	_	12	P	_	_
21	by	_	IN	_	_	12	MNR	_	_
22	innoculating	_	VBG	_	_	21	PMOD	_	_
23	them	_	PRP	_	_	22	OBJ	_	_
24	with	_	IN	_	_	22	ADV	_	_
25	synthetic	_	JJ	_	_	27	NMOD	_	_
26	viral	_	JJ	_	_	27	NMOD	_	_
27	proteins	_	NNS	_	_	24	PMOD	_	_
28	,	_	,	_	_	31	P	_	_
29	Dr.	_	NNP	_	_	30	TITLE	_	_
30	Redfield	_	NNP	_	_	31	SBJ	_	_
31	said	_	VBD	_	_	0	ROOT	_	_
32	.	_	.	_	_	31	P	_	_

1	``	_	``	_	_	3	P	_	_
2	We	_	PRP	_	_	3	SBJ	_	_
3	've	_	VBP	_	_	0	ROOT	_	_
4	demonstrated	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	OBJ	_	_
6	you	_	PRP	_	_	7	SBJ	_	_
7	can	_	MD	_	_	5	SUB	_	_
8	.	_	.	_	_	3	P	_	_
9	''	_	''	_	_	3	P	_	_

1	He	_	PRP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	certain	_	JJ	_	_	4	NMOD	_	_
4	volunteers	_	NNS	_	_	5	SBJ	_	_
5	developed	_	VBD	_	_	2	OBJ	_	_
6	kinds	_	NNS	_	_	5	OBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	antibodies	_	NNS	_	_	7	PMOD	_	_
9	associated	_	VBN	_	_	6	APPO	_	_
10	with	_	IN	_	_	9	ADV	_	_
11	early	_	JJ	_	_	12	NMOD	_	_
12	AIDS	_	NNP	_	_	10	PMOD	_	_
13	.	_	.	_	_	2	P	_	_

1	Other	_	JJ	_	_	2	NMOD	_	_
2	antibodies	_	NNS	_	_	7	SBJ	_	_
3	sparked	_	VBN	_	_	2	APPO	_	_
4	by	_	IN	_	_	3	LGS	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	preparation	_	NN	_	_	4	PMOD	_	_
7	are	_	VBP	_	_	23	OBJ	_	_
8	of	_	IN	_	_	7	PRD	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	sort	_	NN	_	_	8	PMOD	_	_
11	rarely	_	RB	_	_	12	AMOD	_	_
12	present	_	JJ	_	_	10	APPO	_	_
13	in	_	IN	_	_	12	AMOD	_	_
14	large	_	JJ	_	_	15	NMOD	_	_
15	quantities	_	NNS	_	_	13	PMOD	_	_
16	in	_	IN	_	_	12	AMOD	_	_
17	infected	_	JJ	_	_	20	NMOD	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	ill	_	JJ	_	_	18	CONJ	_	_
20	individuals	_	NNS	_	_	16	PMOD	_	_
21	,	_	,	_	_	23	P	_	_
22	he	_	PRP	_	_	23	SBJ	_	_
23	added	_	VBD	_	_	0	ROOT	_	_
24	.	_	.	_	_	23	P	_	_

1	One	_	CD	_	_	7	SBJ	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	mysteries	_	NNS	_	_	2	PMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	AIDS	_	NNP	_	_	5	PMOD	_	_
7	remains	_	VBZ	_	_	0	ROOT	_	_
8	why	_	WRB	_	_	11	DEP	_	_
9	infected	_	JJ	_	_	10	NMOD	_	_
10	people	_	NNS	_	_	11	SBJ	_	_
11	produce	_	VBP	_	_	7	OBJ	_	_
12	large	_	JJ	_	_	13	NMOD	_	_
13	quantities	_	NNS	_	_	11	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	antibodies	_	NNS	_	_	14	PMOD	_	_
16	,	_	,	_	_	11	P	_	_
17	but	_	CC	_	_	11	COORD	_	_
18	deteriorate	_	VBP	_	_	17	CONJ	_	_
19	nonetheless	_	RB	_	_	18	ADV	_	_
20	.	_	.	_	_	7	P	_	_

